According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.64. In 2022 the company made an earnings per share (EPS) of -$4.14 an increase over its 2021 EPS that were of -$4.43.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.68 | -83.68% |
2022 | -$4.14 | -6.46% |
2021 | -$4.43 | 72.87% |
2020 | -$2.56 | -476% |
2019 | $0.68 | -62.12% |
2018 | $1.80 | -1566.67% |
2017 | -$0.12 | -126.47% |
2016 | $0.46 | -74.63% |
2015 | $1.83 | -47.66% |
2014 | $3.49 | -142.11% |
2013 | -$8.29 | -21.45% |
2012 | -$10.55 | -59.43% |
2011 | -$26.00 | -25.53% |
2010 | -$34.91 | -49.17% |
2009 | -$68.68 | 122.22% |
2008 | -$30.91 | 110% |
2007 | -$14.72 | -350% |
2006 | $5.89 | -124% |
2005 | -$24.53 | -28.57% |
2004 | -$34.34 | 27.27% |
2003 | -$26.98 | 0% |
2002 | -$26.98 | 27.91% |
2001 | -$21.10 | -28.33% |
2000 | -$29.44 |